Altered expression of ADAR1, N4BP1, and PSME1 in PBMCs correlated with therapeutic outcomes in HBeAg-negative chronic hepatitis B patients treated with Peg-IFN-α

在接受聚乙二醇干扰素α治疗的HBeAg阴性慢性乙型肝炎患者中，外周血单核细胞（PBMC）中ADAR1、N4BP1和PSME1表达的改变与治疗结果相关。